Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy

William J. Freeman, Eileen C. Rife, Randy Q. Cron · 2026

Read Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy by William J. Freeman, Eileen C. Rife, Randy Q. Cron (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13180542.txt.

Description

William J Freeman, Eileen C Rife, and Randy Q Cron report two children whose lung disease from a severe arthritis resisted standard treatment. Their 2026 case report covers systemic juvenile idiopathic arthritis. Its lung complication can be fatal and often comes with high blood pressure in the lungs and a dangerous immune flare.

Both children stayed ill on conventional therapies, so the team escalated to a pair of strong immune drugs, cyclophosphamide and rituximab, given together. After the combination, both improved markedly. Their fever driving blood marker levels settled and inflammation measures returned to normal. Liver function also recovered. The cases add rare evidence for the pairing in this complication, where best treatment is not yet settled.

Catalog record

CREATORWilliam J. Freeman, Eileen C. Rife, Randy Q. Cron
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13180542

Browse the full library · About the Tower of Babel